We report a patient with a primary form of macular skin atrophy with preceding inflamatory lesionsanetoderma of Jadassohn. Investigations into the role of fibrinolysis in the pathophysiology of this disorder are presented.
by ligating the bleeding vessels using a blunt 'liver needle' and tamponading the spleen in a Dexon mesh. The diaphragm was repaired with continuous nonabsorbable sutures and a second chest drain was inserted.
The patient made a good recovery; there was no evidence of diaphragmatic herniation or paradoxical movement; chest X-ray and real time ultrasonography of the spleen 2 months later were normal. However, there was evidence of Howell-Jolly bodies on the blood film and isotope splenic scan showed a normally sited spleen with reduced uptake (Figure 2 ). Discussion This is the first reported case of splenic conservation by transthoracic repair. It also serves to illustrate some of the principles of management of rupture of the diaphragm.
Since the 1930s, the recommended treatment for ruptured spleen has been splenectomy, which has reduced the mortality ofthis condition from 100% to 27% and was accepted because the spleen was thought to be expendable and not safely sutured'.
Recently, there has been mounting evidence, reviewed by Cooper and Williamson2, in favour of splenic preservation. They describe the various techniques to repair the spleen, including using topical haemostatic agents, splenic sutures with or without buttressing material, ligation of the splenic artery and partial resection; an alternative is autotransplantation. A multicentre non-randomized trial from Norway3 confirms the fidings of previous retrospective studies; splenic conservation is feasible with no greater morbidity or mortality than in patients treated by splenectomy.
We believe splenic preservation can be safe and should be attempted in adults as well as in children, unless it can be proved that splenectomy carries no risk to the patient.
Rupture ofthe diaphragm is increasingly recognized as a complication of blunt trauma, particularly road accidents. Between 3% and 8% of patients requiring laparotomy for blunt trauma are found to have a rupture of the diaphragm4'5; 80% of these are in males", 50% are associated with fractured ribs, 50% with serious intra-abdominal injury7. Herniation of abdominal contents, usually spleen but sometimes stomach, colon or omentum occurs in 70% of cases4'5'8'9.
The diagnosis is clinical and is confirmed radiologically. Chest pain, tachypnoea, mediastinal shift, dullness of the lower chest and bowel sounds in the chest suggest the diagnosis acutely. Chest X-ray may show an elevated hemidiaphragm, loss of diaphragmatic contour or air in the chest. A nasogastric tube may be seen in the chest; gastric opacification with contrast medium and ultrasound are useful aids to diagnosis; as are pneumoperitoneum, peritoneal lavage, radionuclide imaging and computed tomography, in difficult cases where haemorrhage obscures the physical and radiological signs.
This case also demonstrates the importance of differentiating an elevated hemidiaphragm and a herniated hollow viscus'; chest drains must be inserted with care to avoid injury to herniated viscera.
Repair of the diaphragm requires laparotomy, unless there is no evidence of abdominal injury7 when thoracotomy is appropriate. Patients should be prepared for both. Repair involves reduction of any herniated viscus and approximation ofthe edges with strong non-absorbable sutures in one or two layers.
There is a high mortality in such injuries, due to associated visceral and intracranial injuries. If the patient survives, studies show a good functional result of the diaphragmatic repair, with a low incidence of complications (basal atelectasis, wound infection) as in this case7.
The success ofrepair in this patient is supported by the presence offunctioning splenic tissue two months later, as seen on the isotope scan. (Figure 1 ). The examining finger can impress such a lesion passing through a 'rim' of normal skin into the subcutis.
Skin biopsies were taken from an acute papular lesion and an established area of anetoderma. Both biopsies showed a pronounced perivascular inflammatory infiltrate in the upper and mid-dermis, composed of mixed mononuclear inflammatory cells, neutrophils and eosinophils, with accompanying extravasation of erythrocytes. In addition, the established atrophic skin, but not the acute papular lesion, showed an almost complete loss of dermal elastic tissue ( Figure 2 ), with only occasional abnormal twisted degenerative fibres remaining. Direct immunofluorescence was negative.
The following investigations were either normal or negative: full blood count, erythrocyte sedimentation rate, antistreptolysin titre, throat swab, viral titres, copper level, caeruloplasmin level, alpha 1 antitrypsin level, DNA antibodies. Antinuclear factor was 1: 40. L 9 q > £ ; < S t t 2 9 e 4 2 t -5 4 Fibrinolytic studies were done on both blood and tissue. The blood fibrinolytic activity was entirely normal (dilute clot lysis > 8 h; euglobulin clot lysis=7½ h; fibrin plate lysis area:113 mm2; antiplasmin activity=109% of normal plasma; plasminogen activity=94%; Willebrand factor antigen 92 iu/dl). Tissue fibrinolytic activity from an acute papular lesion compared with uninvolved skin was measured, after disintegration of tissue, on a fibrin plate. Results were expressed as equivalents of urokinase standards1. Compared with uninvolved skin, reduced fibrinolytic activity was found in lesional skin (180 units and 50 units urokinase-like activity per gram of tissue, respectively).
Discussion
The primary forms of anetoderma (not preceded by an identifiable skin disease) are divided into those with preceding inflammatory lesions (anetoderma of Jadassohn-Pellizari) and those without preceding inflammatory lesions (anetoderma of Schweninger-Buzzi)2. The present case is typical of the Jadassohn type, with preceding erythematous macules or papules developing into areas of anetoderma. Attempts have been made to subdivide the patients who have urticarial lesions preceding the anetoderma into the Pellizzari type, described in 1884 as 'eritema orticato atrofizzante'3 but we agree with Chargin and Silver3 that this is probably an unwarranted subdivision.
The hallmark clinically ofthe anetodermas (aneto= Greek for slack) is the wrinkled, atrophic area of skin which often forms a bag-like protrusion through which the examining finger sinks into a distinct pit with sharp borders as if into a hernia ring. Various clinical associations have been reported with primary anetodermas, including ocular, bony and cardiac abnormalities4, but whether these are simply coincidental has not been determined.
The characteristic and constant histological finding in anetoderma is a focal or diffuse loss ofelastic tissue in the dermis in established lesions. This may well not be appreciated unless elastic stains are performed ( Figure 2 ). The loss of elastin has been confirmed in similar cases both by electron microscopy5-7 and by reduction in desmosine concentrations (elastin specific cross-link compound) in the affected skin6. Both the acute inflammatory lesion and the established areas of anetoderma showed striking dermal perivascular inflammation. 'T' cell marker studies have previously suggested that the majority of lymphocytes in these infiltrates are helper cells8. It is noteworthy that the clinically non-inflammatory form of anetoderma (Schweninger-Buzzi) has also been reported to show similar inflammatory histological changes to those of the Jadassohn type9.
The aetiology of this condition, and the reason for the destruction of the elastic tissue, is unknown. Because of the anecdotal report of a beneficial therapeutic effect of the anti-fibrinolytic drug E aminocaproic acid on a case of anetoderma of Jadassohn10 we measured fibrinolytic activity in the blood and tissue in the present case. Blood fibrinolytic activity was entirely normal, and that in lesional skin was reduced. This suggests that treatment with a drug which stimulates fibrinolysis, such as Stanozolol'1, could be of therapeutic benefit in the present case, and we propose to evaluate it during the next flare up of his disease. G Menon MA MRCP Department of Paediatrics, Peterborough District Hospital, Thorpe Road, Peterborough Keywords: hypothyroidism; raised thyroxine binding globulin A boy with congenital hypothyroidism and raised thyroxine binding globulin (TBG) is described. In the presence of this rare combination of abnormalities, total thyroid hormone levels overestimated thyroid status, leading to undertreatment of hypothyroidism. Implications for the monitoring ofthyroid replacement are discussed.
Case report
The boy was born at term, in 1972, the only child of unrelated Caucasian parents, with no relevant family history. At birth, his length (0.55 m) and weight (5.0 kg) were, respectively, on and above the 97th centile.
Following resuscitation for mild birth asphyxia, there were no significant neonatal problems. An umbilical hernia was the only abnormality noticed, until, at 21 months, he presented with developmental and growth delay (length 3rd centile, weight 50th centile) and other clinical features of hypothyroidism.
Investigations confirmed the diagnosis: serum thyroxine (T4) 28 nmol/A (normal range 60-140), thyroid stimulating hormone (TSH) 100 mU/1) (normal range 2-10), bone age 4 months. A technetium isotope scan showed no fimctioning thyroid tissue.
His subsequent course was complicated by the involvement over the next 12 years, of 6 At the age of 5 years, his treatment was reduced because of a high T4 level. Over the next 2 years, his treatment dose was such as to achieve high-normal T4 levels, although, noticeably, this was associated with high TSH levels (Figure la ). Although he seemed to be growing appropriately, his bone age was only 3.5 years at 5.3 years.
When he was 7 years old, his treatment was changed to triiodothyronine (20 to 80 ug daily). This suppressed his TSH to normal levels (Figure lb) and his height velocity increased so that he reached the 90th centile by 10.5 years. His bone age at 10.5 years was 8 years.
At this stage, thyroxine was substituted for triiodothyronine, and the dose adjusted mainly according to T4 levels. This resulted in high-normal T4 and high TSH (Figure lc) , with a slowing in height velocity and a weight gain of almost 20 kg in 18 months. At 11.5 years, his bone age was 9 years.
When he was 12 years old, the possibility of a thyroid binding protein abnormality was inivestigated, because of the repeated finding of high TSH values in association with high-normal or supra-normal T4 values. His blood thyroxine binding globulin (TBG) level was highcat 67.4 mg/l (MR 10-32). His parents (who have no siblings) had normal values ofTBG, T4 and T3 (total and free), and TSH.
Subsequently the dose of thyroxine was increased, and is now adjusted to maintain TSH levels in the normal range, irrespective of T4 levels. 
